{
    "id": 28338,
    "fullName": "IRF4 loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "IRF4 loss indicates loss of the IRF4 gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3662,
        "geneSymbol": "IRF4",
        "terms": [
            "IRF4",
            "LSIRF",
            "MUM1",
            "NF-EM5",
            "SHEP8"
        ]
    },
    "variant": "loss",
    "createDate": "07/02/2018",
    "updateDate": "07/02/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14348,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, IRF4 was down-regulated in mantle cell lymphoma cells isolated from patients who responded to Ibrance (palbociclib) therapy compared to cells from nonresponders, and loss of IRF4 induced interferon response and apoptosis in cultured cells, suggesting that IRF4 may be a biomarker predicting sensitivity to Cdk4 inhibition (Cancer Res 2018;78(13 Suppl):Abstract nr 1523).",
            "molecularProfile": {
                "id": 29982,
                "profileName": "IRF4 loss"
            },
            "therapy": {
                "id": 850,
                "therapyName": "Palbociclib",
                "synonyms": null
            },
            "indication": {
                "id": 50746,
                "name": "mantle cell lymphoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11604,
                    "pubMedId": null,
                    "title": "Repression of IRF4 and CYTIP unleashes anti-tumor interferon response in CDK4 inhibitor therapy in mantle cell lymphoma",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/1523"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29982,
            "profileName": "IRF4 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}